Study of 2-HOBA for women with lupus
Part of Heart & circulation, Immune system & allergy, Skin clinical trials.
This trial tests whether a natural compound called 2-HOBA can help women with lupus who also have mildly high blood pressure. It aims to improve blood vessel health and reduce inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older
- You have been diagnosed with lupus by a doctor
- Your lupus medications have not changed in the last 3 months
- You are willing to stop taking NSAID pain relievers (like ibuprofen or naproxen) for 2 weeks before and during the study
- You have slightly elevated blood pressure (systolic between 120 and 160, or diastolic between 80 and 110)
- If you could become pregnant, you are willing to use birth control during and 4 weeks after the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called HB2198 to see if it can help people with moderate to severe lupus. It may be an option for those whose current treatments haven't worked well enough.
This Phase 2 trial tests whether 2-HOBA can improve how “good cholesterol” (HDL) works in people with familial hypercholesterolemia (FH). If HDL works better, it may help lower heart risk markers. You would need to meet several heart, health, and medication-related safety checks.
This trial tests if a medication called 2-HOBA can help with ongoing immune system issues in people with Long COVID who also have POTS. It aims to reduce fatigue and other symptoms by calming overactive immune responses.
This study tests whether an investigational drug can reduce blood pressure in people whose blood pressure is sensitive to salt. It aims to see if the drug helps by calming an overactive immune system.
This study tests an investigational supplement called 2-HOBA to see if it can help people with pulmonary arterial hypertension (PAH), a condition that causes high blood pressure in the lungs. It aims to see if 2-HOBA improves exercise ability and quality of life.
This trial tests whether a daily supplement can safely reduce high levels of lipoprotein(a), a type of fat in the blood linked to heart disease. Participation lasts about 12 weeks and involves regular check-ins.
Hear when a new Systemic Lupus Erthematosus (SLE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.